“It’s adenocarcinoma,” said the voice on the other end of the phone.
I couldn’t believe it.
“Lung cancer? Me? How could that be? I’ve never smoked!” Shock, disbelief, and disappointment filled all the nooks and crannies of my mind and heart.
In January 2021, I went to my PCP…
Source: www.kevinmd.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
